e-Masterclass
on on ILD & PAH
on on ILD & PAH
A Collaborative Endeavor by the World Scleroderma Foundation and Panamerican League of Associations for Rheumatology
A Collaborative Endeavor by the World Scleroderma Foundation and Panamerican League of Associations for Rheumatology
Session 1 - Friday, September 11, 2026 - h 19:00-21:00 CET
Session 2 - Friday, October 9, 2026 - h 19:00-21:00 CET
Session 3 - Friday, November 13, 2026 - h 18:00-20:00 CET
Session 4 - Friday, December 11, 2026 - h 18:00-20:00 CET
SCIENTIFIC ORGANIZERS: Marco Matucci-Cerinic, Yannick Allanore, Carlos Enrique Toro Gutierrez
Registration Form
For all four Sessions
SCIENTIFIC ORGANIZERS
Yannick Allanore
Université Paris Cité, Cochin Hospital, Paris, France
Marco Matucci Cerinic
Università Vita - Salute San Raffaele Milano, Italy
Carlos Enrique Toro Gutierrez
Systemic Sclerosis Fellow, McMaster University, Canada
Laura Alberti
Hospital de Rehabilitación Respiratoria M. Ferrer, Buenos Aires, Argentina
Julián Barahona Correa
Division of Immunology and Rheumatology, Stanford University, USA
Luis Javier Cajas Santana
Rheumatologist. National University of Colombia
Karla Chacón
Instituto Nacional de Enfermedades Respiratorias, México
Christopher Denton
University College London and Royal Free Hospital London, UK
Juan Ignacio Enghelmayer
Hospital de Clínicas, University of Buenos Aires, Argentina
Fernanda Godinho de Amorim
Medical Rheumatologist, Paulista School of Medicine
Cristiane Kayzer
Paulista Medical School, Federal University of São Paulo, Brazil
Nader Khalidi
Division Director of Rheumatology, McMaster University, Canada
Dinesh Khanna
University of Michigan, USA
Sandra Fabiana Montoya
Ramos Mejia Hospital, Buenos Aires, Argentina
Janet Pope
University of Western Ontario, Canada
Gerardo Quintana
National University of Colombia
Virginia Rodríguez
University of Medicine, Montevideo, Uruguay
Jorge Rojas Serrano
Instituto Nacional de Enfermedades Respiratorias, México
Manuela Rubio Rivera
Hospital Universitario del Valle, Cali, Colombia
Percival Sampaio Barros
University of São Paulo, Brazil
Gabriela Tabaj
Respiratory physician, Cetrángolo Hospital Buenos Aires, Argentina
Veronica Wolff Cecchi
National Institute of Respiratory Diseases, Santiago, Chile
PRELIMINARY PROGRAMME
Fully virtual online format
Session 1 – Friday, September 11, 2026
Pathophysyology, epidemiology and imaging of ILD & PAH in CTD
Pathophysyology, epidemiology and imaging of ILD & PAH in CTD
11:00–13:00 – Costa Rica, El Salvador, Honduras, Nicaragua
12:00–14:00 – Colombia, Ecuador, Panama, Peru
13:00–15:00 – Canada (Eastern Time), Cuba, Bolivia, Venezuela, Dominican Republic
14:00–16:00 – Argentina, Brazil (Brasília Time), Paraguay, Uruguay
19:00–21:00 CEST – Central European Summer Time (Italy and Central Europe)
19:00 Session introduction & objectives
• Marco Matucci Cerinic – WSF President – University Vita Salute San Raffael, Milan, Italy
• Carlos Enrique Toro – PANLAR President – Systemic Sclerosis Fellow, McMaster University, Canada
19:05 Pathophysiology of CTD-ILD
• Karla Chacón – Instituto Nacional de Enfermedades Respiratorias, México
19:20 Pathophysiology of CTD-PAH
• Christophe Guignabert – Université Paris-Saclay
19:35 Epidemiology of lung involvement in CTD: parenchyma and vessels
• TBD – University of Lyon
19:50 Burden of disease: mortality, disability in CTD-PAH & CTD-ILD
• Yannick Allanore – Université Paris Cité
20:05 Imaging the parenchyma in CTD-ILD
• Paola Orausclio – Centro de Diagnostico Rossi, Buenos Aires, Argentina.
20:20 Imaging the heart and the vessels in CTD-PAH
• Antonia Maria Valenzuela Vergara – Pontificia Universidad Católica de Chile
20:35 Interactive discussion and questions
• Alejandra Babini – Universidad Nacional de Córdoba, Facultad de Medicina
20:55 Key messages & wrap‑up
• Marco Matucci Cerinic – WSF President – University Vita Salute San Raffael, Milan, Italy
• Carlos Enrique Toro – PANLAR President – Systemic Sclerosis Fellow, McMaster University, Canada
12:00–14:00 – Colombia, Ecuador, Panama, Peru
13:00–15:00 – Canada (Eastern Time), Cuba, Bolivia, Venezuela, Dominican Republic
14:00–16:00 – Argentina, Brazil (Brasília Time), Paraguay, Uruguay
19:00–21:00 CEST – Central European Summer Time (Italy and Central Europe)
Click to view programme
19:00 Session introduction & objectives
• Marco Matucci Cerinic – WSF President – University Vita Salute San Raffael, Milan, Italy
• Carlos Enrique Toro – PANLAR President – Systemic Sclerosis Fellow, McMaster University, Canada
19:05 Pathophysiology of CTD-ILD
• Karla Chacón – Instituto Nacional de Enfermedades Respiratorias, México
19:20 Pathophysiology of CTD-PAH
• Christophe Guignabert – Université Paris-Saclay
19:35 Epidemiology of lung involvement in CTD: parenchyma and vessels
• TBD – University of Lyon
19:50 Burden of disease: mortality, disability in CTD-PAH & CTD-ILD
• Yannick Allanore – Université Paris Cité
20:05 Imaging the parenchyma in CTD-ILD
• Paola Orausclio – Centro de Diagnostico Rossi, Buenos Aires, Argentina.
20:20 Imaging the heart and the vessels in CTD-PAH
• Antonia Maria Valenzuela Vergara – Pontificia Universidad Católica de Chile
20:35 Interactive discussion and questions
• Alejandra Babini – Universidad Nacional de Córdoba, Facultad de Medicina
20:55 Key messages & wrap‑up
• Marco Matucci Cerinic – WSF President – University Vita Salute San Raffael, Milan, Italy
• Carlos Enrique Toro – PANLAR President – Systemic Sclerosis Fellow, McMaster University, Canada
Session 2 – Friday, October 9, 2026
Screening or Missing the Window? Risk Stratification in CTD-ILD
Screening or Missing the Window? Risk Stratification in CTD-ILD
11:00–13:00 – Costa Rica, El Salvador, Honduras, Nicaragua
12:00–14:00 – Colombia, Ecuador, Panama, Peru
13:00–15:00 – Canada (Eastern Time), Cuba, Bolivia, Venezuela, Dominican Republic
14:00–16:00 – Argentina, Brazil (Brasília Time), Paraguay, Uruguay
19:00–21:00 CEST – Central European Summer Time (Italy and Central Europe)
19:00 Session introduction & learning goals
19:05 Clinical Case 1: Rapidly progressive ILD
19:15 ILD screening strategies across CTD
19:30 Progressive pulmonary fibrosis in CTD
19:40 Clinical Case 2: What do not miss in PAH prognostic evaluation
19:55 PAH screening algorithms in CTD
20:10 PAH tools for follow-up in CTD-PH
20:25 Is exercise testing a good outcome in both ILD and PAH?
20:40 Panel discussion & questions
20:55 Key messages & wrap up
12:00–14:00 – Colombia, Ecuador, Panama, Peru
13:00–15:00 – Canada (Eastern Time), Cuba, Bolivia, Venezuela, Dominican Republic
14:00–16:00 – Argentina, Brazil (Brasília Time), Paraguay, Uruguay
19:00–21:00 CEST – Central European Summer Time (Italy and Central Europe)
Click to view programme
19:00 Session introduction & learning goals
19:05 Clinical Case 1: Rapidly progressive ILD
19:15 ILD screening strategies across CTD
19:30 Progressive pulmonary fibrosis in CTD
19:40 Clinical Case 2: What do not miss in PAH prognostic evaluation
19:55 PAH screening algorithms in CTD
20:10 PAH tools for follow-up in CTD-PH
20:25 Is exercise testing a good outcome in both ILD and PAH?
20:40 Panel discussion & questions
20:55 Key messages & wrap up
Session 3 – Friday, November 13, 2026
Immunosuppression, Antifibrotics, Vascular Therapies, or All Of Them Together?
Immunosuppression, Antifibrotics, Vascular Therapies, or All Of Them Together?
10:00–12:00 – Costa Rica, El Salvador, Honduras, Nicaragua
11:00–13:00 – Colombia, Ecuador, Panama, Peru
12:00–14:00 – Canada (Eastern Time), Cuba, Bolivia, Venezuela, Dominican Republic
13:00–15:00 – Argentina, Brazil (Brasília Time), Paraguay, Uruguay
18:00–20:00 CEST – Central European Summer Time (Italy and Central Europe)
18:00 Opening session: therapeutic paradigms and objectives
18:05 Clinical Case: Patient with ILD, progressing to PAH
18:15 Immunosuppression in ILD: from csDMARD to targeted therapies
18:30 Antifibrotic therapies and CTD-ILD
18:45 Which combination therapy and when in CTD-ILD?
19:00 Should we use the ILD pattern to guide the treatment in CTD?
19:15 Combination therapy standard and emerging therapies in PAH
19:30 Managing overlapping ILD and PAH phenotypes (group 3 PH)
19:45 Panel discussion & questions
19:55 Key messages & wrap up
11:00–13:00 – Colombia, Ecuador, Panama, Peru
12:00–14:00 – Canada (Eastern Time), Cuba, Bolivia, Venezuela, Dominican Republic
13:00–15:00 – Argentina, Brazil (Brasília Time), Paraguay, Uruguay
18:00–20:00 CEST – Central European Summer Time (Italy and Central Europe)
Click to view programme
18:00 Opening session: therapeutic paradigms and objectives
18:05 Clinical Case: Patient with ILD, progressing to PAH
18:15 Immunosuppression in ILD: from csDMARD to targeted therapies
18:30 Antifibrotic therapies and CTD-ILD
18:45 Which combination therapy and when in CTD-ILD?
19:00 Should we use the ILD pattern to guide the treatment in CTD?
19:15 Combination therapy standard and emerging therapies in PAH
19:30 Managing overlapping ILD and PAH phenotypes (group 3 PH)
19:45 Panel discussion & questions
19:55 Key messages & wrap up
Session 4 – Friday, December 11, 2026
New Frontiers in CTD Lung Disease: Rehabilitation and Evolving Models of Care
New Frontiers in CTD Lung Disease: Rehabilitation and Evolving Models of Care
10:00–12:00 – Costa Rica, El Salvador, Honduras, Nicaragua
11:00–13:00 – Colombia, Ecuador, Panama, Peru
12:00–14:00 – Canada (Eastern Time), Cuba, Bolivia, Venezuela, Dominican Republic
13:00–15:00 – Argentina, Brazil (Brasília Time), Paraguay, Uruguay
18:00–20:00 CEST – Central European Summer Time (Italy and Central Europe)
18:00 Session introduction & objectives
18:05 Clinical Case: Lung trasplantation in CTD-ILD
18:15 Timing for lung transplantation referral
18:30 Oxygen therapy and rehabilitation
18:45 Acute exacerbations and critical care
19:00 Cellular therapy: breakthrough in ILD?
19:15 Clinical trials landscape in CTD ILD and CTD-PAH
19:30 What should include a lung clinic in CTD patients
19:50 Key messages & course synthesis
11:00–13:00 – Colombia, Ecuador, Panama, Peru
12:00–14:00 – Canada (Eastern Time), Cuba, Bolivia, Venezuela, Dominican Republic
13:00–15:00 – Argentina, Brazil (Brasília Time), Paraguay, Uruguay
18:00–20:00 CEST – Central European Summer Time (Italy and Central Europe)
Click to view programme
18:00 Session introduction & objectives
18:05 Clinical Case: Lung trasplantation in CTD-ILD
18:15 Timing for lung transplantation referral
18:30 Oxygen therapy and rehabilitation
18:45 Acute exacerbations and critical care
19:00 Cellular therapy: breakthrough in ILD?
19:15 Clinical trials landscape in CTD ILD and CTD-PAH
19:30 What should include a lung clinic in CTD patients
19:50 Key messages & course synthesis
This e-Masterclass is supported by a medical education grant of